Investor immunity to cryptocurrency 'disease' is growing, says Barclays
FILE PHOTO: A Barclays bank building is seen at Canary Wharf in London, Britain May 17, 2017. REUTERS/Stefan Wermuth/File Photo
By Tommy Wilkes and Tom Finn
LONDON (Reuters) - The investment mania for cryptocurrencies is like an infectious disease whose transmission rate may be declining, Barclays said on Tuesday, concluding their combined market capitalization has probably already peaked.
Cryptocurrencies hit a collective value of close to $800 billion in December and January, when prices jumped.
Since then a sharp selloff has left them with a capitalization of around $260 billion, according to Coinmarketcap.com, $115 billion of that being in the biggest and best-known cryptocurrency, bitcoin.
The combined figure was unlikely to climb back beyond a range of $660 billion to $780 billion, the British bank said in an analysis, with any long-term demand for cryptocurrencies coming from "low-trust" sectors of the global economy.
Barclays
The bank divided them into three groups: "Infected individuals, susceptible individuals who are vulnerable but not yet infected and those who are immune," said Marvin Barth, head of global FX strategy.
"Like infection, transmission is by word-of-mouth, via blogs, news reports and personal anecdotes," he told journalists.
The bank said that former cryptocurrency holders were developing "immunity to further investment."
Critics say digital currencies are little more than a giant Ponzi scheme and regulators have warned investors that all their money is at risk. With prices
Supporters say cryptocurrencies and the technology behind them have the potential to do away with traditional fiat currencies and transform how we store money and pay for goods.
Barclays said that it had reached its market capitalization estimates using generous assumptions of money demand for transactions and wealth storage in "low-trust sectors".
(Editing by Kit Rees and John Stonestreet)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
- Jefferies Downgrades IDP Education (IEL:AU) (IDPUF) to Hold
- Moderna jumps premarket after Phase 3 trial, Target slides
Create E-mail Alert Related Categories
Analyst Comments, Forex, ReutersRelated Entities
Barclays, BitcoinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share